New surgical mesh aims to improve breast reconstruction outcomes

NCT ID NCT06575192

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 7 times

Summary

This study tests a device called ARTIA, a special tissue matrix used during implant-based breast reconstruction after mastectomy. About 264 adults who need immediate reconstruction will receive ARTIA to see if it reduces major complications like infection or implant failure. The goal is to offer a safer and more effective option for women rebuilding their breasts after cancer surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ARTIA Reconstructive Tissue Matrix (a surgical mesh device)
What this could lead to: If successful, ARTIA could provide a safer, more effective option for women undergoing implant-based breast reconstruction after mastectomy, potentially reducing complications.
What could go wrong: This is a pivotal study, but results may not apply to all patients. Risks include surgical complications like infection or implant failure, and the device may not outperform existing options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST RECONSTRUCTION

Contacts and locations

Locations

AG Aesthetic Center /ID# 264233
COMPLETED

Vancouver, Washington, 98660, United States
Atrium Health Wake Forest Baptist Medical Center /ID# 264382
RECRUITING

Winston-Salem, North Carolina, 27157, United States
Cedars-Sinai Medical Center /ID# 268326
RECRUITING

Los Angeles, California, 90048, United States
East Tennessee State University /ID# 264321
RECRUITING

Johnson City, Tennessee, 37614, United States
Endeavor Health - Health Center & Immediate Care - Northbrook /ID# 266302
RECRUITING

Northbrook, Illinois, 60062, United States
Erlanger Health System /ID# 266608
RECRUITING

Chattanooga, Tennessee, 37403, United States
Johns Hopkins Hospital /ID# 265917
RECRUITING

Baltimore, Maryland, 21287, United States
NYU Langone Medical Center /ID# 265621
COMPLETED

New York, New York, 10016-6402, United States
Northwell Health Clinical Trials Office /ID# 268076
COMPLETED

Lake Success, New York, 11042, United States
Ohio State Havener Eye Institute - Columbus /ID# 266253
RECRUITING

Columbus, Ohio, 43212, United States
Private Practice - Dr. Wayne Lee /ID# 281661
NOT_YET_RECRUITING

Brandon, Florida, 33511, United States
Rush University Medical Center /ID# 275935
RECRUITING

Chicago, Illinois, 60612-3841, United States
Rutgers New Jersey Medical School - Newark /ID# 264187
RECRUITING

Newark, New Jersey, 07103, United States
South Bay Plastic Surgeons /ID# 264192
COMPLETED

Torrance, California, 90505, United States
Stanford University Medical Center CTRU - 800 Welch Road /ID# 264196
RECRUITING

Palo Alto, California, 94304, United States
The Plastics Clinic and Spa /ID# 281483
NOT_YET_RECRUITING

Draper, Utah, 84020, United States
The University of Texas MD Anderson Cancer Center /ID# 264020
RECRUITING

Houston, Texas, 77030, United States
University Of California Irvine Medical Center /ID# 267428
RECRUITING

Orange, California, 92868, United States
University Of Colorado - Anschutz Medical Campus /ID# 268627
RECRUITING

Aurora, Colorado, 80045, United States
University of Florida College of Medicine /ID# 267485
RECRUITING

Gainesville, Florida, 32610, United States
University of Nevada - Main Campus /ID# 264017
COMPLETED

Las Vegas, Nevada, 89154, United States
University of Virginia /ID# 265098
COMPLETED

Charlottesville, Virginia, 22903, United States
Washington University /ID# 264029
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.